RSS calls Citizenship Bill passage a 'courageous step'

News Network
December 12, 2019

Nagpur, Dec 12: RSS general secretary Bhaiyyaji Joshi on Thursday congratulated Prime Minister Narendra Modi and Union Home Minister Amit Shah for the passage of the Citizenship (Amendment) Bill in Parliament and described it as a "courageous step".

Talking to reporters here, Joshi said all should rise above their political compulsions and welcome the bill.

He said the stand of the Rashtriya Swayamsevak Sangh (RSS) has always been that a Hindu who comes to India because of persecution in another country cannot be termed as an intruder, but a refugee.

The bill, which seeks to provide Indian citizenship to non-Muslim refugees from Pakistan, Afghanistan and Bangladesh, was passed by the Rajya Sabha on Wednesday. The Lok Sabha passed it on Monday.

Joshi dubbed it as a "courageous step" and thanked the BJP-led central government, the prime minister and the Home Minister for taking the initiative.

"When the country was partitioned, there was a demand for division on religious grounds. However, India did not have any such idea of forming a 'religious country'. But, the country was partitioned over this issue and the leaders then had accepted it," he said.

If partition had not taken place on religious grounds, then many incidents thereafter would not have happened, the RSS general secretary said.

"Subsequently, Pakistan and Bangladesh declared themselves as Islamic states and there were doubts then about what place the minorities residing there will get...because as per the agreement, it was said that the minorities will not face any injustice," said Joshi.

Unfortunately, this did not happen and the Hindus residing there in large numbers "became the target of persecution", he said.

Looking at the census conducted from time-to-time, the number of Hindus residing in Afghanistan, Pakistan and Bangladesh came down drastically, he said.

"The question arises where these people went, and it comes to fore that many of them came to India," he said.

The Hindus persecuted in these countries had no other place to go than India, where they could live a life of respect and security and hence, they kept coming to India.

"However, due to the lack of provisions in the law, these people were deprived of the citizenship of India for many years. There was a huge need that these persecuted people may not be called as 'intruders' but termed as refugees, and this was outstanding from quite some time," Joshi said.

"There is a need for these refugees to have a respectable life and common rights in our country. But, a lot of time passed and these refugees had to wait," Joshi said.

But, the present government has taken a "very good step" and the minority communities from Pakistan, Bangladesh and Afghanistan will get a respectable place in India, he said.

The bill provides an "assurance" (of a respectable life) to the refugees who come to India, he added.

"I feel this bill has assured the minorities coming from these countries, and we welcome them and express our happiness for them. Now, their refugee status will end and they will live as citizens and will get benefits of the citizens' rights in the country," he said.

Joshi said all should rise above political compulsions and welcome this bill.

"The Home Minister has repeatedly said that the bill does not pose any threat to the Muslim community in our country and no one's rights will be curtailed," he said.

On protests in some northeastern states following the passage of the bill, Joshi said, "Some states have certainly witnessed unrest, but I am confident that the Centre will take steps to check rumours in the north-east and clear doubts of the people there. They will keep living as earlier."

Joshi also expressed hope that the refugees who get Indian citizenship will be able to live peacefully.

Comments

ALTHAF
 - 
Thursday, 12 Dec 2019

It was a plan of RSS to implement this bill. Anyhow you will not succeed in your communal plan. Time to boycot RSS and its agenda.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 8,2020

Jamnagar, Apr 7: A 14-month-old baby boy, who had tested positive for coronavirus in Gujarat's Jamnagar district on April 5, died of multiple organ failure on Tuesday, said officials.

The toddler, son of a migrant labourer-couple having no recent travel history, died in the evening at a government hospital in Jamnagar, said an official release.

He was in a critical condition ever since he was admitted to the hospital, it said.

The boy, who tested positive for coronavirus two days ago, was as on ventilator support and eventually died due to multiple organ failure, said the release.

He becomes the youngest patient to succumb to COVID-19 in Gujarat, where the death toll has now gone up to 16.

The baby was the first and the only case of coronavirus infection so far in entire Jamnagar district and the youngest to be diagnosed with the disease in Gujarat.

Ever since he tested coronavirus positive, the authorities had been tracing the source of his infection.

His parents are from Uttar Pradesh and work as casual labourers in factories in the port city.

His parents, who have no travel history in the recent past, are asymptomatic (not showing symptoms) and kept under quarantine, officials said.

The locality where the couple resides in Dared village near Jamnagar city has been put under complete lockdown to check the spread of the virus, they said.

Gujarat has so far recorded 175 coronavirus positive cases and 16 fatalities.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 20,2020

New Delhi, Jan 20: Surging inflation and slowing growth are raising serious concerns about the future growth prospects of the economy and as a remedial measure the government should resolve supply-side hurdles and ensure more stringent governance norms, a report said on Monday.

According to the Dun and Bradstreet Economy forecast, even though the Index of Industrial Production (IIP) turned positive in November 2019, it is likely to remain subdued.

"Slowdown in consumption and investment along with high inflationary pressures, geopolitical issues and uncertainty over the recovery of the economic growth are likely to keep IIP subdued," the report noted.

Dun and Bradstreet expect IIP to remain around 1.5-2.0 percent during December 2019.

As per government data, industrial output grew 1.8 percent in November, turning positive after three months of contraction, on account of growth in the manufacturing sector.

On the price front, uneven rainfall along with floods in many states and geopolitical issues have led to a surge in headline inflation even as demand remains muted.

The Consumer Price Index (CPI) in December rose to about five-and-half year high of 7.35 percent from 5.54 percent in November, mainly driven by high vegetable prices.

"The sharp rise in inflation has constrained monetary policy stimulus while revenue shortfall has placed limits on the government expenditure," Dun & Bradstreet India Chief Economist Arun Singh said.

According to Singh, growth-supporting measures and deceleration in growth are likely to cause slippage in fiscal deficit target by a wider margin.

"The government should focus on taking small steps to address the slowdown; in particular, resolve the supply-side hurdles and ensure more stringent governance norms," Singh said.

Unless these concerns are addressed through a comprehensive policy framework, it will not be easy for India to clock a sustainable growth rate to become a USD 5 trillion economy, he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.